CNS Startup Myrobalan Therapeutics Raises $24M Series A
Biotech company Myrobalan Therapeutics announced Wednesday it has raised a $24 million series A to develop treatments for degenerative CNS conditions....To view the full article, register now.
Already a subscriber? Click here to view full article